z-logo
open-access-imgOpen Access
Population analysis of the pregnancy-related modifications in lopinavir pharmacokinetics and their possible consequences for dose adjustment
Author(s) -
Marion BouillonPichault,
Vincent Jullien,
Élie Azria,
E. Pannier,
Ghislaine Firtion,
Anne Krivine,
Alexandra Compagnucci,
Olivier Tauléra,
Laurent Finkielsztejn,
Stéphanie Chhun,
Guillem Pons,
Odile Launay,
JeanMarc Tréluyer
Publication year - 2009
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkp123
Subject(s) - lopinavir , medicine , pregnancy , pharmacokinetics , population , regimen , lopinavir/ritonavir , gestation , gestational age , obstetrics , human immunodeficiency virus (hiv) , viral load , antiretroviral therapy , immunology , biology , environmental health , genetics
To investigate the possible necessity of an increase in lopinavir dose during pregnancy in order to achieve the concentrations previously defined as predictive of virological efficacy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom